Dong-E-E-Jiao Co Ltd
SZSE:000423
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
45.21
71.59
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Dong-E-E-Jiao Co Ltd
Dong-E-E-Jiao Co Ltd
Capital Expenditures
Dong-E-E-Jiao Co Ltd
Capital Expenditures Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Dong-E-E-Jiao Co Ltd
SZSE:000423
|
Capital Expenditures
-¥80.1m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
23%
|
CAGR 10-Years
13%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Capital Expenditures
-¥219.6m
|
CAGR 3-Years
46%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Capital Expenditures
-¥103.9m
|
CAGR 3-Years
30%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-2%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Capital Expenditures
-¥1.6B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-23%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Capital Expenditures
-¥632.5m
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-24%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Capital Expenditures
-¥81.9m
|
CAGR 3-Years
-75%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Dong-E-E-Jiao Co Ltd
Glance View
In the heart of China's Shandong Province lies Dong-E-E-Jiao Co Ltd, a company deeply rooted in the traditions of Chinese medicinal culture yet driven by the dynamics of a modern corporation. Established in the early 1950s, Dong-E-E-Jiao takes its name from its primary product, "ejiao," a traditional medicine derived from donkey-hide gelatin. Traditionally used in Chinese medicine for its purported benefits in nourishing blood and enhancing vitality, ejiao forms the cornerstone of Dong-E-E-Jiao's product line. At the company’s state-of-the-art facilities, these gelatin products are manufactured with a blend of time-tested practices and contemporary techniques, ensuring quality and efficacy that cater to both domestic and international markets. Dong-E-E-Jiao’s approach to business revolves around harnessing the age-old wisdom of Chinese medicine, coupled with a solid understanding of global health and wellness trends. Beyond gelatin products, the company has diversified into related segments, offering nutritional supplements, beauty products, and contemporary health foods—all linked by their heritage in traditional Chinese medicine. This diversification strategy has opened multiple revenue streams, allowing Dong-E-E-Jiao to expand its market reach while anchoring its brand in authenticity and trust. Sales are driven through a mix of direct retail channels, partnerships with pharmacies, and an increasing online presence, ensuring that their products remain accessible to a broad array of consumers. In this way, Dong-E-E-Jiao balances the dual imperatives of tradition and innovation to drive its business forward.
See Also
What is Dong-E-E-Jiao Co Ltd's Capital Expenditures?
Capital Expenditures
-80.1m
CNY
Based on the financial report for Sep 30, 2024, Dong-E-E-Jiao Co Ltd's Capital Expenditures amounts to -80.1m CNY.
What is Dong-E-E-Jiao Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
13%
Over the last year, the Capital Expenditures growth was -75%. The average annual Capital Expenditures growth rates for Dong-E-E-Jiao Co Ltd have been -32% over the past three years , 23% over the past five years , and 13% over the past ten years .
You don't have any saved screeners yet
